Patents

News

FTC launches probe of Teva over ‘improper’ patents; report

Shares in Teva Pharmaceutical have dipped sharply after reports that the Federal Trade Commission (FTC) has opened an investigation into the company focusing on improperly listed patents in

News

Senate Majority Whip and Senate Judiciary Committee chair Dick Durbin (D-IL)

US senators accuse pharma firms of abusing patent system

Lawmakers across the political divide have accused the pharma industry of abusing the patent system to keep the prices of their products as high as possible in a combative

News

FTC steps up campaign on junk patents with warning letters

The US Federal Trade Commission (FTC) has expanded its campaign against so-called ‘junk’ patents intended to extend market exclusivity and block generic rivals.

R&D

Patentability and predictability in AI-assisted drug discove...

Artificial intelligence (AI) and machine learning (ML) are ushering in a new era in drug discovery.

News

Biden may order compulsory licensing in drug pricing move

The White House said today that it may take enforced ownership of patents on medicines developed with public funding if their manufacturers set their prices too high.

News

FTC challenges dozens of ‘improper’ US drug patents

The financial regulator in the US has sent letters to 10 companies that it claims have improperly listed patents in the FDA’s ‘Orange Book’ in order to block generic rival

FTC launches probe of Teva over ‘improper’ patents; report

US senators accuse pharma firms of abusing patent system

FTC steps up campaign on junk patents with warning letters

Patentability and predictability in AI-assisted drug discove...

Biden may order compulsory licensing in drug pricing move

FTC challenges dozens of ‘improper’ US drug patents

Tenpoint eyes presbyopia drug launch after FDA nod

How to meet your physicians where they are online

Patents

Editor's Picks